332
Participants
Start Date
January 24, 2018
Primary Completion Date
November 22, 2019
Study Completion Date
November 22, 2019
CNTX-4975-05
Receiving CNTX-4975-05 injection
Placebo
Receiving Placebo injection
Ortho Virginia, Arlington
Charlottesville Medical Research Center, LLC, Charlottesville
Drug Studies America, Marietta
Georgia Institute for Clinical Research, LLC, Marietta
Atlanta Orthopaedic Institute, LLC, Stockbridge
Avail Clinical Research, LLC, DeLand
Jewett Orthopaedic, Orlando
M&M Medical Center, Inc, Miami
Clinical Research of West Florida, Inc., Tampa
Tampa Bay Medical Research, Inc, Clearwater
Sensible Healthcare, LLC, Ocoee
Alabama Orthopaedic Center - Research, Birmingham
Cahaba Research, Inc, Birmingham
Coastal Clinical Research, Inc, Mobile
Bone Joint & Spine Surgeons, Inc, Toledo
MediSphere Medical Research Center, LLC, Evansville
Medical Research Associates, Inc, Traverse City
Sundance Clinical Research, LLC, St Louis
Mid America PolyClinic, Overland Park
Clinical Investigations of Texas, Plano
Metroplex Clinical Research Center, Dallas
Tekton Research, Inc, Austin
Noble Clinical Research, LLC, Tucson
Clinical Research Consortium, Las Vegas
Core Healthcare Group, Cerritos
Providence Clinical Research, North Hollywood
Biosolutions Clinical Research Center, La Mesa
Encompass Clinical Research, Spring Valley
Medical Associates Research Group, San Diego
Orange County Research Institute, Anaheim
Tufts Medical Center, Boston
Tristan Medical Enterprises PC, dba, North Attleboro
Hassman Research Institute, Berlin
Lead Sponsor
Centrexion Therapeutics
INDUSTRY